Driven by Our Promise
It began with a promise. CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL and we are driven by our promise.
CSL Behring
Saving lives and improving the quality of life for people with serious and rare conditions is what we do. Listening to our patients while continuing to introduce new innovations that address unmet medical needs or enhance current treatments is how we do it. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our patients’ needs.
http://www.cslbehring.com/
CSL Plasma
CSL Plasma, a division of CSL Behring, operates one of the world's largest and most efficient plasma collection networks. CSL Plasma has more than 230 centers in the U.S. and Europe and, with its integrated manufacturing platform, operates production facilities in the U.S., Germany, Switzerland and Australia. We use the most sophisticated production methods available, meeting or exceeding stringent international safety and quality standards.
https://www.cslplasma.com/
CSL Seqirus
With corporate offices in Maidenhead, UK, Seqirus has manufacturing plants in the US, UK, Germany and Australia with extensive research and production expertise. They are a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally.
http://www.seqirus.com/
CSL Vifor
CSL Vifor is a strong and rapidly growing presence in nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by our founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need.